These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 29314747)

  • 1. Real-time monitoring of antibody glycosylation site occupancy by in situ Raman spectroscopy during bioreactor CHO cell cultures.
    Li MY; Ebel B; Paris C; Chauchard F; Guedon E; Marc A
    Biotechnol Prog; 2018 Mar; 34(2):486-493. PubMed ID: 29314747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring mAb cultivations with in-situ raman spectroscopy: The influence of spectral selectivity on calibration models and industrial use as reliable PAT tool.
    Santos RM; Kessler JM; Salou P; Menezes JC; Peinado A
    Biotechnol Prog; 2018 May; 34(3):659-670. PubMed ID: 29603907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quick generation of Raman spectroscopy based in-process glucose control to influence biopharmaceutical protein product quality during mammalian cell culture.
    Berry BN; Dobrowsky TM; Timson RC; Kshirsagar R; Ryll T; Wiltberger K
    Biotechnol Prog; 2016; 32(1):224-34. PubMed ID: 26587969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of Raman spectroscopy in monoclonal antibody producing continuous systems for downstream process intensification.
    Yilmaz D; Mehdizadeh H; Navarro D; Shehzad A; O'Connor M; McCormick P
    Biotechnol Prog; 2020 May; 36(3):e2947. PubMed ID: 31837253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Raman based chemometric model development for glycation and glycosylation real time monitoring in a manufacturing scale CHO cell bioreactor process.
    A Gibbons L; Rafferty C; Robinson K; Abad M; Maslanka F; Le N; Mo J; Clark K; Madden F; Hayes R; McCarthy B; Rode C; O'Mahony J; Rea R; O'Mahony Hartnett C
    Biotechnol Prog; 2022 Mar; 38(2):e3223. PubMed ID: 34738336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of IgG glycosylation by in situ and real-time estimation of specific growth rate of CHO cells cultured in bioreactor.
    Li MY; Ebel B; Blanchard F; Paris C; Guedon E; Marc A
    Biotechnol Bioeng; 2019 May; 116(5):985-993. PubMed ID: 30636319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of spectroscopy technologies for improved monitoring of cell culture processes in miniature bioreactors.
    Rowland-Jones RC; van den Berg F; Racher AJ; Martin EB; Jaques C
    Biotechnol Prog; 2017 Mar; 33(2):337-346. PubMed ID: 28271638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuning monoclonal antibody galactosylation using Raman spectroscopy-controlled lactic acid feeding.
    W Eyster T; Talwar S; Fernandez J; Foster S; Hayes J; Allen R; Reidinger S; Wan B; Ji X; Aon J; Patel P; Ritz DB
    Biotechnol Prog; 2021 Jan; 37(1):e3085. PubMed ID: 32975043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Raman-based dynamic feeding strategies using real-time glucose concentration monitoring system during adalimumab producing CHO cell cultivation.
    Domján J; Fricska A; Madarász L; Gyürkés M; Köte Á; Farkas A; Vass P; Fehér C; Horváth B; Könczöl K; Pataki H; Nagy ZK; Marosi GJ; Hirsch E
    Biotechnol Prog; 2020 Nov; 36(6):e3052. PubMed ID: 32692473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-line and real-time prediction of recombinant antibody titer by in situ Raman spectroscopy.
    André S; Cristau LS; Gaillard S; Devos O; Calvosa É; Duponchel L
    Anal Chim Acta; 2015 Sep; 892():148-52. PubMed ID: 26388485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioreactor scale up and protein product quality characterization of piggyBac transposon derived CHO pools.
    Rajendra Y; Balasubramanian S; Peery RB; Swartling JR; McCracken NA; Norris DL; Frye CC; Barnard GC
    Biotechnol Prog; 2017 Mar; 33(2):534-540. PubMed ID: 28188692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of spectroscopic process analytical technology for rapid quality evaluation during preparation of CHO cell culture media.
    Ou J; Cui W; Zhao Y; Tang Y; Williams A; Wasalathanthri D; Xu J; Lee J; Borys MC; Khetan A
    Biotechnol Prog; 2024; 40(5):e3477. PubMed ID: 38699906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heat shock protein 27 overexpression in CHO cells modulates apoptosis pathways and delays activation of caspases to improve recombinant monoclonal antibody titre in fed-batch bioreactors.
    Tan JG; Lee YY; Wang T; Yap MG; Tan TW; Ng SK
    Biotechnol J; 2015 May; 10(5):790-800. PubMed ID: 25740626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Automated Data Generation for Raman Spectroscopy Calibrations in Multi-Parallel Mini Bioreactors.
    Graf A; Woodhams A; Nelson M; Richardson DD; Short SM; Brower M; Hoehse M
    Sensors (Basel); 2022 Apr; 22(9):. PubMed ID: 35591088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. At-line raman spectroscopy and design of experiments for robust monitoring and control of miniature bioreactor cultures.
    Rowland-Jones RC; Jaques C
    Biotechnol Prog; 2019 Mar; 35(2):e2740. PubMed ID: 30378770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential gene expression of a feed-spiked super-producing CHO cell line.
    Reinhart D; Damjanovic L; Castan A; Ernst W; Kunert R
    J Biotechnol; 2018 Nov; 285():23-37. PubMed ID: 30157452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlling the time evolution of mAb N-linked glycosylation, Part I: Microbioreactor experiments.
    Villiger TK; Roulet A; Périlleux A; Stettler M; Broly H; Morbidelli M; Soos M
    Biotechnol Prog; 2016 Sep; 32(5):1123-1134. PubMed ID: 27254475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of chemometric models applied to Raman spectroscopy for monitoring key metabolites of cell culture.
    Rafferty C; Johnson K; O'Mahony J; Burgoyne B; Rea R; Balss KM
    Biotechnol Prog; 2020 Jul; 36(4):e2977. PubMed ID: 32012476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Process intensification in fed-batch production bioreactors using non-perfusion seed cultures.
    Yongky A; Xu J; Tian J; Oliveira C; Zhao J; McFarland K; Borys MC; Li ZJ
    MAbs; 2019; 11(8):1502-1514. PubMed ID: 31379298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perfusion seed cultures improve biopharmaceutical fed-batch production capacity and product quality.
    Yang WC; Lu J; Kwiatkowski C; Yuan H; Kshirsagar R; Ryll T; Huang YM
    Biotechnol Prog; 2014; 30(3):616-25. PubMed ID: 24574326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.